JACNX
Price
$30.51
Change
-$0.29 (-0.94%)
Updated
Oct 17 closing price
Net Assets
5B
VIMAX
Price
$358.27
Change
+$0.63 (+0.18%)
Updated
Oct 17 closing price
Net Assets
201.28B
Interact to see
Advertisement

JACNX vs VIMAX

Header iconJACNX vs VIMAX Comparison
Open Charts JACNX vs VIMAXBanner chart's image
Janus Henderson Contrarian D
Price$30.51
Change-$0.29 (-0.94%)
VolumeN/A
Net Assets5B
Vanguard Mid Cap Index Admiral
Price$358.27
Change+$0.63 (+0.18%)
VolumeN/A
Net Assets201.28B
JACNX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
JACNX vs. VIMAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JACNX is a Hold and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 201B vs. JACNX (5B). VIMAX pays higher dividends than JACNX: VIMAX (1.48) vs JACNX (0.39). JACNX was incepted earlier than VIMAX: JACNX (26 years) vs VIMAX (24 years). JACNX (0.64) is less costly to investors than VIMAX (0.05). JACNX is a more actively managed with annual turnover of: 42.00 vs. VIMAX (16.00). JACNX has a lower initial minimum investment than VIMAX: JACNX (2500) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 7.58 vs. JACNX (-3.76). VIMAX return over 5 years is better than : 57.32 vs. JACNX (30.25).
JACNXVIMAXJACNX / VIMAX
Total Expense Ratio0.640.051,280%
Annual Report Gross Expense Ratio0.640.051,280%
Fund Existence26 years24 years-
Gain YTD10.1449.707105%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5B201B2%
Annual Yield % from dividends0.391.4826%
Returns for 1 year-3.767.58-50%
Returns for 3 years41.1549.7083%
Returns for 5 years30.2557.3253%
Returns for 10 years66.31140.9347%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVX1.980.02
+1.02%
NOVONIX Limited
CXM7.620.05
+0.66%
Sprinklr
ATIIU10.59N/A
N/A
Archimedes Tech SPAC Partners II Co
ABVC2.92N/A
N/A
ABVC BioPharma
MDGL438.90-3.23
-0.73%
Madrigal Pharmaceuticals